Resmed

News

Reuters - 4 giorni fa

U.S. Amerant Bancorp, BlackRock, Equinix

U.S. RESEARCH ROUNDUP-Amerant Bancorp, BlackRock, Equinix Oct 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amerant Bancorp, BlackRock and Equinix, on Tuesday. HIGHLIGHTS * Amerant Bancorp Inc AMTB.N : Stephens raises to overweight from equal-weight * BlackRock BLK.N : JP Morgan raises target price to $864 from $774 * Equinix Inc EQIX.O : JP Morgan raises target price to $975 from $950 * Interpublic Group of Comp

Reuters - 5 giorni fa

Resmed Unveils New Five-Year Financial Outlook

BRIEF-Resmed Unveils New Five-Year Financial Outlook Sept 30 (Reuters) - Resmed Inc RMD.N : RESMED UNVEILS 2030 STRATEGY TO DRIVE GROWTH, PROFITABILITY, AND SHAREHOLDER RETURNS RESMED: NEW FIVE-YEAR FINANCIAL OUTLOOK INCLUDES HIGH-SINGLE-DIGIT REVENUE GROWTH RESMED: NEW FIVE-YEAR FINANCIAL OUTLOOK INCLUDES EARNINGS GROWTH HIGHER THAN REVENUE GROWTH

Reuters - 2 settimane fa

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change West Pharmaceutical Services Inc WST.N +4.9% Dollar Tree Inc DLTR.OQ +3.3% Bio Rad Laboratories Inc BIO.N +3.2% Bath & Body Works Inc BBWI.N +3.2% General Motors Co GM.N +3.2% Bottom Performers Percent Change Resmed Inc RMD.N -4.8% Ave

Reuters - 2 settimane fa

U.S. STOCKS United States Steel, Ambac Financial, Apple

BUZZ-U.S. STOCKS ON THE MOVE-United States Steel, Ambac Financial, Apple Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes slipped in volatile trading on Wednesday ahead of the Federal Reserve's highly anticipated first interest rate cut in more than four years, with jitters over the magnitude of the reduction dominating mood.

Reuters - 2 settimane fa

U.S. STOCKS Powerfleet, NMI, Vivos Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Powerfleet, NMI, Vivos Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were flat on Wednesday as investors stepped onto the sidelines ahead of the Federal Reserve's highly anticipated first interest rate cut in more than four years, with bets favoring a 50-basis-point reduction.

Reuters - 2 settimane fa

ResMed falls as Wolfe Research downgrades to 'underperform' on 1 risks

BUZZ-ResMed falls as Wolfe Research downgrades to 'underperform' on GLP-1 risks ** Shares of medical device maker ResMed RMD.N fall 6.1% to $235.65 ** Brokerage Wolfe Research downgrades to "underperform" from "peer perform", sets PT of $180 * Expect significant risk of disruption in patient demand next year as FDA likely to approve Eli Lilly's LLY

Reuters - 4 settimane fa

KeyBanc says sleep apnea device makers to benefit from new Apple Watch feature

BUZZ-KeyBanc says sleep apnea device makers to benefit from new Apple Watch feature ** Brokerage KeyBanc Capital Markets says it views the news of Apple AAPL.O launching sleep apnea detection in its new Watch Series 10, and existing Watch Series 9 and Watch Ultra 2 as positive for medical device makers Resmed RMD.N and Inspire Medical Systems INSP.

Reuters - 1 mese fa

U.S. STOCKS Lumen Technologies, Insulet, PDD Holdings

BUZZ-U.S. STOCKS ON THE MOVE-Lumen Technologies, Insulet, PDD Holdings Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 rose on Tuesday in mixed trading ahead of a highly anticipated quarterly report from Nvidia and economic data expected later in the week.

Reuters - 1 mese fa

U.S. STOCKS Eli Lilly, JD.com, Super Micro Computer

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, JD.com, Super Micro Computer Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were lower on Tuesday, weighed down by tech-related stocks, as caution prevailed ahead of a highly anticipated earnings report from Nvidia and crucial economic data expected later in the week.

Reuters - 2 mesi fa

Resmed Expands Board By Appointing Christopher Delorefice

BRIEF-Resmed Expands Board By Appointing Christopher Delorefice Aug 15 (Reuters) - Resmed Inc RMD.N : RESMED EXPANDS ITS BOARD OF DIRECTORS AND APPOINTS HEALTHCARE EXECUTIVE AND SEASONED FINANCE LEADER CHRISTOPHER DELOREFICE TO ITS BOARD Source text for Eikon: ID:nGNX7KRqxN Further company coverage: RMD.N

Reuters - 2 mesi fa

Australia shares slump more than 3% as US recession worries trigger sell-off

Australia shares slump more than 3% as US recession worries trigger sell-off ASX 200 posts worst session since June 2022 ASX volatility index at more than 2-year high Tech stocks lose 6.6%, financials drop 5% RBA policy decision due on Tuesday Updates to close By Himanshi Akhand and Rajasik Mukherjee Aug 5 (Reuters) - Australian shares slumped more than 3% in their worst trading session in over two years on Monday, joining a global sell-off in riskier assets after weak U.S.

Reuters - 2 mesi fa

Australia-listed shares of ResMed climb to 1-year high as analysts hike PT

BUZZ-Australia-listed shares of ResMed climb to 1-year high as analysts hike PT ** ASX-listed shares of ResMed RMD.AX RMD.N rise as much as 7% to A$34.020, their highest since Aug 2, 2023 ** Analysts at J.P. Morgan lift their price target on the medical equipment maker to A$37 from A$34.5 after its quarterly results ** Macquarie analysts raise PT to A$36.25 from A$35.40 ** U.S.-based co on Friday reported adj.

Reuters - 2 mesi fa

Resmed Inc reports results for the quarter ended in January - Earnings Summary

Resmed Inc reports results for the quarter ended in January - Earnings Summary Resmed Inc RMD.N reported quarterly adjusted earnings of $2.08 per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of $1.60. The mean expectation of twelve analysts for the quarter was for earnings of $2.07 per share.

Reuters - 2 mesi fa

Resmed Inc reports results for the quarter ended in June - Earnings Summary

Resmed Inc reports results for the quarter ended in June - Earnings Summary Resmed Inc RMD.N reported quarterly adjusted earnings of $2.08 per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $1.60. The mean expectation of twelve analysts for the quarter was for earnings of $2.07 per share.

Reuters - 2 mesi fa

ResMed meets estimates on steady demand for its sleep apnea devices

ResMed meets estimates on steady demand for its sleep apnea devices Aug 1 (Reuters) - Medical equipment maker ResMed RMD.N reported fourth-quarter revenue in line with estimates on Thursday, on steady demand for its sleep apnea treatment devices. The company's quarterly revenue rose 9% to $1.22 billion, in line with estimates of $1.22 billion. ResMed makes ventilators and machines that provide continuous and bilateral positive airway pressure, known as CPAP and BIPAP, which are used for non-inva

Reuters - 2 mesi fa

Resmed Q4 Adjusted EPS USD 2.08 Vs. IBES Estimate USD 2.07

BRIEF-Resmed Q4 Adjusted EPS USD 2.08 Vs. IBES Estimate USD 2.07 Aug 01 (Reuters) - Resmed Q4 EPS USD 1.98. Q4 revenue USD 1,200 million vs. IBES estimate USD 1,217 million Q4 adjusted gross margin 59.1% Q4 gross margin 58.5%

Reuters - 2 mesi fa

Resmed Inc <RMD.N> expected to post earnings of $2.07 a share - Earnings Preview

Resmed Inc expected to post earnings of $2.07 a share - Earnings Preview Resmed Inc RMD.N , RMD is expected to show a rise in quarterly revenue when it reports results on August 1 for the period ending June 30 2024 The San Diego California-based company is expected to report a 8.4% increase in revenue to $1.217 billion from $1.12 billion a year ago, according to the mean estimate from 13 analysts, based on LSEG data.

Reuters - 2 mesi fa

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change ON Semiconductor Corp ON.OQ +12.2% Revvity Inc RVTY.N +8.7% Resmed Inc RMD.N +5.5% Tesla Inc TSLA.OQ +4.9% McDonald's Corp MCD.N +4.2% Bottom Performers Percent Change Enphase Energy Inc ENPH.OQ -5.2% Southwest Airlines Co LUV.N -3.3%

Reuters - 2 mesi fa

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change ON Semiconductor Corp ON.OQ +13.3% Dexcom Inc DXCM.OQ +6.2% Revvity Inc RVTY.N +5.5% Resmed Inc RMD.N +4.7% Tesla Inc TSLA.OQ +4.6% Bottom Performers Percent Change Constellation Brands Inc STZ.N -3.0% Franklin Resources Inc BEN.N -2.7

Reuters - 2 mesi fa

U.S. STOCKS Hartford Financial, Avantor, WesBanco

BUZZ-U.S. STOCKS ON THE MOVE-Hartford Financial, Avantor, WesBanco Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street bounced back on Friday with the blue-chip Dow leading the charge as some megacap tech and chip stocks recovered from the week's pummeling, while a largely in-line key inflation reading kept bets of an early rate cut alive.

Condizioni

Asset popolari

Disclaimer: le entità di XM Group forniscono servizi di sola esecuzione e accesso al nostro servizio di trading online, che permette all'individuo di visualizzare e/o utilizzare i contenuti disponibili sul sito o attraverso di esso; non ha il proposito di modificare o espandere le proprie funzioni, né le modifica o espande. L'accesso e l'utilizzo sono sempre soggetti a: (i) Termini e condizioni; (ii) Avvertenza sui rischi e (iii) Disclaimer completo. Tali contenuti sono perciò forniti a scopo puramente informativo. Nello specifico, ti preghiamo di considerare che i contenuti del nostro servizio di trading online non rappresentano un sollecito né un'offerta ad operare sui mercati finanziari. Il trading su qualsiasi mercato finanziario comporta un notevole livello di rischio per il tuo capitale.

Tutto il materiale pubblicato sul nostro servizio di trading online è unicamente a scopo educativo e informativo, e non contiene (e non dovrebbe essere considerato come contenente) consigli e raccomandazioni di carattere finanziario, di trading o fiscale, né informazioni riguardanti i nostri prezzi di trading, offerte o solleciti riguardanti transazioni che possano coinvolgere strumenti finanziari, oppure promozioni finanziarie da te non richieste.

Tutti i contenuti di terze parti, oltre ai contenuti offerti da XM, siano essi opinioni, news, ricerca, analisi, prezzi, altre informazioni o link a siti di terzi presenti su questo sito, sono forniti "così com'è", e vanno considerati come commenti generali sui mercati; per questo motivo, non possono essere visti come consigli di investimento. Dato che tutti i contenuti sono intesi come ricerche di investimento, devi considerare e accettare che non sono stati preparati né creati seguendo i requisiti normativi pensati per promuovere l'indipendenza delle ricerche di investimento; per questo motivo, questi contenuti devono essere considerati come comunicazioni di marketing in base alle leggi e normative vigenti. Assicurati di avere letto e compreso pienamente la nostra Notifica sulla ricerca di investimento non indipendente e la nostra Informativa sul rischio riguardante le informazioni sopra citate; tali documenti sono consultabili qui.

Resmed

News

Condizioni

Asset popolari

Chat live XM